To the biggest index providers, some of the best-performing US growth stocks of the past two years were value stocks, including a memory chipmaker, a couple of disk-drive companies, and a ...

Working with such a learned person will prevent being scammed by a glitzy commercial. Unfortunately, a growing majority of Americans cannot afford the luxury of a primary-care doctor, now in short ...

Instacart's stock is a much better bargain for long-term investors than rival DoorDash, according to Charles Lemonides, the founder of ValueWorks. It's natural for investors to be fixated on companies ...

U.K. government bond yields and sterling fell after the Bank of England held interest rates steady at 3.75% and announced plans to overhaul its approach to reducing its balance sheet. The central bank ...

Trading at a 21% discount, this wide-moat stock is a rare find.

Walmart will sell Medicare Advantage plans as part of a new partnership with SCAN Health, a nonprofit health insurer that recently partnered with Costco Wholesale on a similar initiative.

Shares of Intel (INTC) soared 8.3% Thursday morning, while those of AI chip makers Marvell Technology (MRVL) and Advanced Micro Devices (AMD) were up 5% and 4.9%, respectively. Arm Holdings' ...

Novo Nordisk said a key European Medicines Agency committee recommended the approval of its Frehemgo drug for hemophilia A. The Danish drugmaker said Thursday that it expects to launch the medicine in ...

Higher mortgage rates are further dampening an already stagnant housing market. Housing supply has crept up to a seven-year high, as buyers remain scarce. There were 58% more home sellers than buyers ...

Prior to the deal's announcement, The Wall Street Journal reported in March that Fertitta Entertainment was in talks to buy Caesars for around $7 billion, fending off a competing offer from ...

AstraZeneca and Daiichi Sankyo's breast-cancer drug Enhertu won approval from the drug-cost watchdog for routine use in England, after the regulator changed its recommendation following the U.S.-U.K.

--The pending home sales index, a leading indicator of house sales based on contract signings, rose 0.3% in August to 71.2. Economists polled by The Wall Street Journal had forecast a 0.5% increase.